Cargando…
Neuroprotective activity of a virus‐safe nanofiltered human platelet lysate depleted of extracellular vesicles in Parkinson's disease and traumatic brain injury models
Brain administration of human platelet lysates (HPL) is a potential emerging biotherapy of neurodegenerative and traumatic diseases of the central nervous system. HPLs being prepared from pooled platelet concentrates, thereby increasing viral risks, manufacturing processes should incorporate robust...
Autores principales: | Delila, Liling, Nebie, Ouada, Le, Nhi Thao Ngoc, Barro, Lassina, Chou, Ming‐Li, Wu, Yu‐Wen, Watanabe, Naoto, Takahara, Masayasu, Buée, Luc, Blum, David, Devos, David, Burnouf, Thierry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842020/ https://www.ncbi.nlm.nih.gov/pubmed/36684076 http://dx.doi.org/10.1002/btm2.10360 |
Ejemplares similares
-
The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates
por: Nebie, Ouada, et al.
Publicado: (2019) -
Human platelet lysate biotherapy for traumatic brain injury: preclinical
assessment
por: Nebie, Ouada, et al.
Publicado: (2021) -
Can the administration of platelet lysates to the brain help treat neurological disorders?
por: Nebie, Ouada, et al.
Publicado: (2022) -
Nanofiltration of growth media supplemented with human platelet lysates for pathogen-safe xeno-free expansion of mesenchymal stromal cells
por: Barro, Lassina, et al.
Publicado: (2020) -
Past and Future of Neurotrophic Growth Factors Therapies in ALS: From Single Neurotrophic Growth Factor to Stem Cells and Human Platelet Lysates
por: Gouel, Flore, et al.
Publicado: (2019)